MolecularMD, Ventana Partner on PTEN Detection Study | GenomeWeb

NEW YORK (GenomeWeb News) – MolecularMD today said that it has partnered with Ventana Medical Systems to study and compare methods of PTEN detection and expression.

PTEN is a tumor suppressor gene that is mutated in many cancers and is a regulator of the PI3-kinase pathway.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.